Bruce Carlson[email protected]Compliance and RegulationRomanian IVD market worth watching, rose to $464M in 2022The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.May 31, 2023Compliance and RegulationU.K. IVD market grows to $4.6 billion; Brexit not a factorThe U.K. market is expected to grow just under 3% per year for the next five years, the report said, faster than Italy, France, or the Netherlands, and at about the same rate as Germany.May 4, 2023Compliance and RegulationDeclining COVID-19 test market may still reach $25M in 2023: ReportDespite a decline in sales, COVID-19 is expected to represent one of the larger single-disease categories in IVD testing, according to Kalorama. Rapid testing, mostly antigen-based, will hold up the market while growth drops in lab-based PCR testing.April 28, 2023Compliance and RegulationPoint-of-care IVD sales rose to $45 billion in 2022Numerous trends will combine to enable a growing market. According to the Kalorama report, growth of 3.3% per year is expected over the forecast period from 2022 to 2027.April 19, 2023Compliance and RegulationBrazilian IVD market rises to $1.7BThe demand for clinical testing equipment in Brazil is partly driven by an aging population, Kalorama noted. People 65 and over are expected to account for 14.1% of the total population by 2032.April 18, 2023Compliance and RegulationSwedish IVD market estimated at $804 million in 2022: Kalorama InformationCritical care point-of-care tests, used for assessment of emergency room (ER) and intensive care unit (ICU) patients in hospitals or ambulatory settings, are expected to grow about three times faster in Sweden than in the U.S. over the next five years.March 31, 2023Compliance and RegulationU.S. IVD market reaches $53 billionAccording to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.March 22, 2023Compliance and RegulationIVD physician office market was $8.3 billion in 2022: KaloramaAn increase in the number of diseases for which physician offices are often the first to test is influencing physician office lab IVD revenue growth.January 23, 2023Liquid Biopsy$1.3 billion liquid biopsy market represents the present and future of clinical oncology: KaloramaThe liquid biopsy market can be segmented by the type of analyte detected and analyzed. There are four main categories: circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and other analytes, and multiple analytes.January 19, 2023Compliance and RegulationHighly competitive molecular diagnostics market reaches $21B: KaloramaThe market largely consists of COVID-19 sales, but future growth in the market will be fueled by other applications, according to Kalorama Information.November 8, 2022Page 1 of 7Next PageTop StoriesLawsuitLegal team highlights cautionary clinical laboratory fraud caseClinical laboratory litigation indicates growing trend of cases filed by nontraditional whistleblowers.Emerging TechnologyWhat's coming in clinical genomics?Policy and RegulationLab leaders advised to maintain communication with regulatory agencies during blackoutLawsuitFederal judge dismisses pathology group antitrust caseSponsor ContentBody composition in patients treated with Ozempic